当前位置:首页 - 行情中心 - 君实生物-U(688180) - 财务分析 - 现金流量表

君实生物-U

(688180)

  

流通市值:342.58亿  总市值:458.93亿
流通股本:7.66亿   总股本:10.27亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,311,599,772.63740,358,831.821,836,170,338.41,334,950,275.33
  收到的税费返还35,251,559.5626,804,625.4210,546,104.0910,546,104.09
  收到其他与经营活动有关的现金57,606,816.4736,256,368.2769,811,541.8551,386,223.25
  经营活动现金流入小计1,404,458,148.66803,419,825.511,916,527,984.341,396,882,602.67
  购买商品、接受劳务支付的现金928,536,616.33469,391,325.131,732,587,358.041,319,202,006.33
  支付给职工以及为职工支付的现金644,115,292.77292,997,853.31,216,708,662.84929,835,245.36
  支付的各项税费53,955,675.3927,815,876.7589,149,699.7569,060,203.94
  支付其他与经营活动有关的现金107,238,897.5137,545,966.83311,923,473.25192,257,231.65
  经营活动现金流出小计1,733,846,482827,751,022.013,350,369,193.882,510,354,687.28
  经营活动产生的现金流量净额-329,388,333.34-24,331,196.5-1,433,841,209.54-1,113,472,084.61
二、投资活动产生的现金流量:
  收回投资收到的现金1,180,000,000481,065,293.221,901,811,816.6901,371,865.77
  取得投资收益收到的现金5,104,981.681,781,547.959,430,216.084,834,002.45
  处置固定资产、无形资产和其他长期资产收回的现金净额8,016,042.53801,865,0001,865,000
  收到的其他与投资活动有关的现金14,493,280.737,546,867.6944,160,556.1133,177,403.78
  投资活动现金流入小计1,207,614,304.91490,394,088.861,957,267,588.79941,248,272
  购建固定资产、无形资产和其他长期资产支付的现金313,755,421.96161,199,762.48690,987,533.01620,759,009.17
  投资支付的现金1,425,794,592649,000,0002,159,000,0001,404,000,012.5
  支付其他与投资活动有关的现金20,918,197.3121,820,04162,189.34-
  投资活动现金流出小计1,760,468,211.27832,019,803.482,850,049,722.352,024,759,021.67
  投资活动产生的现金流量净额-552,853,906.36-341,625,714.62-892,782,133.56-1,083,510,749.67
三、筹资活动产生的现金流量:
  吸收投资收到的现金939,583,277.12-1,501,566.251,566.25
  其中:子公司吸收少数股东投资收到的现金--1,501,566.251,566.25
  取得借款收到的现金1,700,523,498.011,421,654,234.12,306,748,582.681,928,788,474.47
  收到其他与筹资活动有关的现金-676,829.086,350,285.824,641,807.39
  筹资活动现金流入小计2,640,106,775.131,422,331,063.182,314,600,434.751,933,431,848.11
  偿还债务支付的现金1,181,404,221.57997,243,377.51,174,018,295.57943,497,136.23
  分配股利、利润或偿付利息支付的现金47,909,712.6623,008,576.1773,790,126.9352,050,486.65
  支付其他与筹资活动有关的现金26,428,498.9315,301,114.2643,646,237.2737,854,029
  筹资活动现金流出小计1,255,742,433.161,035,553,067.931,291,454,659.771,033,401,651.88
  筹资活动产生的现金流量净额1,384,364,341.97386,777,995.251,023,145,774.98900,030,196.23
四、汇率变动对现金及现金等价物的影响376,249.04-791,648.4312,014,641.06-6,855,136.19
五、现金及现金等价物净增加额502,498,351.3120,029,435.7-1,291,462,927.06-1,303,807,774.24
  加:期初现金及现金等价物余额2,486,679,108.822,486,679,108.823,778,142,035.883,778,142,035.88
  期末现金及现金等价物余额2,989,177,460.132,506,708,544.522,486,679,108.822,474,334,261.64
补充资料:
  净利润-465,673,412.19--1,380,108,858.26-
  资产减值准备50,738,807.77-88,178,776.72-
  固定资产和投资性房地产折旧122,580,963.27-244,829,609.17-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧122,580,963.27-244,829,609.17-
  无形资产摊销16,445,543.77-31,734,565.71-
  长期待摊费用摊销3,679,404.57-11,504,314.2-
  处置固定资产、无形资产和其他长期资产的损失-7,583,182.57--12,777,848.8-
  固定资产报废损失170,781.24-938,428.84-
  公允价值变动损失-55,513,847.65-47,678,755.74-
  财务费用24,821,791.58-6,033,960.32-
  投资损失20,282,414.15-23,553,900.59-
  递延所得税-1,870,126.71-16,350,840.82-
  其中:递延所得税资产减少-1,870,126.71-16,350,840.82-
  存货的减少10,192,870.84--159,273,263.21-
  经营性应收项目的减少58,824,950.68-54,205,110-
  经营性应付项目的增加-120,501,141.3--415,293,504.21-
  其他-1,184,653.77--10,673,190.91-
  现金的期末余额2,989,177,460.13-2,486,679,108.82-
  减:现金的期初余额2,486,679,108.82-3,778,142,035.88-
  现金及现金等价物的净增加额502,498,351.31--1,291,462,927.06-
公告日期2025-08-272025-04-262025-03-282024-10-30
审计意见(境内)标准无保留意见
TOP↑